Please use this identifier to cite or link to this item: https://doi.org/10.1039/DT9950003721
Title: L-Methionine increases the rate of reaction of 5′-guanosine monophosphate with the anticancer drug cisplatin: Mixed-ligand adducts and reversible methionine binding
Authors: Barnham, K.J.
Djuran, M.I.
Del Socorro Murdoch, P.
Ranford, J.D. 
Sadler, P.J.
Issue Date: 1995
Citation: Barnham, K.J., Djuran, M.I., Del Socorro Murdoch, P., Ranford, J.D., Sadler, P.J. (1995). L-Methionine increases the rate of reaction of 5′-guanosine monophosphate with the anticancer drug cisplatin: Mixed-ligand adducts and reversible methionine binding. Journal of the Chemical Society, Dalton Transactions (22) : 3721-3726. ScholarBank@NUS Repository. https://doi.org/10.1039/DT9950003721
Abstract: L-Methionine (L-HMet) increased the rate of reaction of the anticancer drug cisplatin, cis-[PtCl2(NH3)2], with guanosine 5′-monophosphate (5′-GMP) at pH 7. The course of the reaction has been elucidated by 1H and [1H, 15N] NMR spectroscopy. Novel intermediates detected and characterized include cis-[Pt(5′-GMP-N7)(L-HMet-S)(NH3)2] 2+ and [Pt(L-Met-S,N)(5′-GMP-N7)(NH3)]+ (charges on 5′-GMP ignored), the formation of which involves ammine release. Monodentate S-bound L-HMet can co-ordinate reversibly, whereas S,N-chelated L-Met is much less reactive. Thus methionine residues in peptides and proteins could play a role in the transfer of Pt onto DNA. Comparative reactions of [Pt(en)Cl2] (en = 1,2-diaminoethane) have also been investigated.
Source Title: Journal of the Chemical Society, Dalton Transactions
URI: http://scholarbank.nus.edu.sg/handle/10635/94164
ISSN: 14727773
DOI: 10.1039/DT9950003721
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

86
checked on Jul 13, 2018

WEB OF SCIENCETM
Citations

73
checked on Jul 4, 2018

Page view(s)

67
checked on Jun 29, 2018

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.